Sort by
Converging Signaling Networks Drive Taste Bud Morphogenesis, Turnover, and Regeneration
In Young Jo
,Jin-Woo Kim
,Beomjong Song
,Yujeong Song
,Jae Kyeom Kim
,Jeong-Oh Shin
Posted: 04 May 2026
Protocol Waists and the Developmental Hourglass
Steven A. Frank
Posted: 04 May 2026
Acoustic Vibration as Mechanical Stimulation Modulates Actin Organization in Yeast
Mehrta Shirzadian
,Emanuel Gollob
,Christoph Reiter
,Ulla Rauter
,Manuel Paschinger
,Carolina Caballero
,Paul Gruendorfer
,Jana Vojtová
,Mark Rinnerthaler
,Klaus Spiess
Posted: 30 April 2026
Vascular Regeneration and Blood Flow Recovery in Glaucoma
Susannah Waxman
,Adriana Di Polo
Posted: 28 April 2026
Non-Tumorigenic Mesangiogenic Progenitor Cells (MPCs) Spontaneously Form Vascularized Xenografts in Athymic Nude Mice
Simone Pacini
,Marina Montali
,Paolo Domenico Parchi
,Paola Orlandi
,Serena Barachini
,Enza Polizzi
,Angela Pucci
,Guido Bocci
Background: Mesangiogenic Progenitor cells (MPCs) were first described in 2008 in cultures of human bone marrow mononuclear cells (hBM-MNCs) aimed at isolating mesenchymal stromal cells (MSCs) using human autologous serum. A selective culture method was subsequently developed to isolate MPCs with a high degree of purity, yielding approximately 1% of the total plated cells. Since their initial description, MPCs have demonstrated the ability to differentiate into highly clonogenic MSCs while retaining early vasculogenic potential. Gene expression profiling of MPCs revealed constitutive expression of pluripotency-associated transcription factors such as OCT-4 and NANOG, as well as SOX15 instead of SOX2, suggesting a possible molecular mechanism that sustains MPC plasticity, defined as the “adult Oct-4 circuit”. Although the expression of these pluripotency-associated markers has been hypothesized to represent a distinctive adult molecular circuit, concerns regarding the tumorigenic potential of MPCs are reasonable and have not yet explored. Methods: Here, we present data from the tumorigenicity test in partial compliance with WHO recommendations of two different MPC-derived cell products in athymic nude mice. Results: Histomorphometric analysis of nodules excised from animals at 6, 8, or 12 weeks post-cell transplantation excluded tumor formation and demonstrated the ability of MPCs to generate homogeneous and organized tissue through distinct phases: an “early” vasculogenic phase, followed by remodeling of the newly formed microvascular network and the deposition of structured, aligned collagen fibers. Conclusions: MPCs do not possess intrinsic tumorigenic potential and spontaneously form vascularized xenogenic tissue four weeks after injection into the subcutaneous space.
Background: Mesangiogenic Progenitor cells (MPCs) were first described in 2008 in cultures of human bone marrow mononuclear cells (hBM-MNCs) aimed at isolating mesenchymal stromal cells (MSCs) using human autologous serum. A selective culture method was subsequently developed to isolate MPCs with a high degree of purity, yielding approximately 1% of the total plated cells. Since their initial description, MPCs have demonstrated the ability to differentiate into highly clonogenic MSCs while retaining early vasculogenic potential. Gene expression profiling of MPCs revealed constitutive expression of pluripotency-associated transcription factors such as OCT-4 and NANOG, as well as SOX15 instead of SOX2, suggesting a possible molecular mechanism that sustains MPC plasticity, defined as the “adult Oct-4 circuit”. Although the expression of these pluripotency-associated markers has been hypothesized to represent a distinctive adult molecular circuit, concerns regarding the tumorigenic potential of MPCs are reasonable and have not yet explored. Methods: Here, we present data from the tumorigenicity test in partial compliance with WHO recommendations of two different MPC-derived cell products in athymic nude mice. Results: Histomorphometric analysis of nodules excised from animals at 6, 8, or 12 weeks post-cell transplantation excluded tumor formation and demonstrated the ability of MPCs to generate homogeneous and organized tissue through distinct phases: an “early” vasculogenic phase, followed by remodeling of the newly formed microvascular network and the deposition of structured, aligned collagen fibers. Conclusions: MPCs do not possess intrinsic tumorigenic potential and spontaneously form vascularized xenogenic tissue four weeks after injection into the subcutaneous space.
Posted: 28 April 2026
Modeling the Clockwork of Bone: A Narrative Review of Experimental Approaches to Circadian Rhythm in Bone Metabolism
Xiang Gao
,Xinyuan Cai
,Andreas K. Nussler
Posted: 24 April 2026
The Great Debate: Regulated Cell Death in Fungi and the Role of Metacaspases
Derek Wilkinson
Posted: 23 April 2026
High Content Analysis of 3D Chondrogenic Spheroids Derived from Primary Cells In Vitro
Lucija Voga
,Tilen Burnik
,Maša Kandušer
,Matjaž Jeras
,Janja Zupan
,Andreja Trojner Bregar
Posted: 22 April 2026
Rho GTPases in Bone and Tooth Development and Diseases
Xiaofang Wang
,Sanjaya Thapa
,Bikash Lamichhane
,Yongxu Zhang
Posted: 21 April 2026
Wee Kinases, Big Impact: Wee and Myt Kinases as Critical Regulators of Meiotic Progression
Shannon Pfeiffer
,Lourds M. Fernando
,Anna K. Allen
,Aimee Jaramillo-Lambert
Posted: 17 April 2026
Gestational Week 20 as the Mechanobiological Inflection Point of Retroperitoneal Fascial Lamination: A Poisson Effect Model
Hiromu Tokuchi
Posted: 15 April 2026
Chemokine-Independent VLA-4/VCAM-1–Mediated Rolling and Arrest of B16 Melanoma Cells Under Shear
Robert H. Eibl
Posted: 14 April 2026
Topology Before Function: The Bauplan as the Structural Limit of Biological Execution
Tahir Rahman
Posted: 13 April 2026
Molecular Advances in Male Infertility and Fertility: Importance of Redox Regulation and Oxidative Stress
Robert J. Aitken
,Monica H. Vazquez-Levin
,João S. Hallak
,Thiago A. Teixeira
,Jorge Hallak
Posted: 13 April 2026
The NTR/Prodrug Revolution: Tools for Controlling Cell Loss and Regeneration
Gha-Hyun J. Kim
,Michael J. Parsons
Posted: 08 April 2026
Magnetic‐Assisted Fractionation of Bone Marrow Cells into Subsets Differing in CD45 Expression Levels, Surface Phenotypes and Functional Properties
Kandarakov O. F.
,Polyakova N. S.
,Belyavsky A. V.
Posted: 07 April 2026
Use of the J774A.1 Cell Line as a Model in the In Vitro Study of Extracellular Vesicle Secretion from Histiocytic Sarcoma in Patients with Bacterial Co-Infections
Francisco Sierra-López
,Susana Bernardo-Hernández
,Lidia Baylón-Pacheco
,Verónica Ivonne Hernández-Ramírez
,Vanessa Iglesias-Vázquez
,Rosa Martha Morales-López
,Juan Carlos Fernández Hernández
,Gustavo Acosta Altamirano
,Patricia Talamás-Rohana
,José Luis Rosales-Encina
+1 authors
Posted: 06 April 2026
From Disease to Pregnancy: Rethinking Cardiac Remodeling Through Fibroblast, Immune Cell, and Hormonal Interactions
Emily B. Ruggiero
,Wayne Carver
,Daping Fan
,Edie C. Goldsmith
,Holly A. LaVoie
Posted: 02 April 2026
Orchestration of Endothelial and Osteogenic Marker Expression During Osteogenesis
Sydney Chen
,Yan Zhao
,Nikki Chen
,Xiuju Wu
,Li Zhang
,Zheng Jing
,Lei Qi
,Xinjiang Cai
,Kristina I. Boström
,Yucheng Yao
Posted: 02 April 2026
Epigenomic Biomarker Discovery from Biomedical Literature: AI and Text Mining Toward Health Monitoring Frameworks
Ji-Hye Oh
,Hee-Jo Nam
,Su-Hyun Seo
,Hyun-Seok Park
Posted: 01 April 2026
of 39